Drug Database
Back to search

Poland· PL-100189916

Cusimolol 0,5%

A timolol product containing timololum, registered in Poland by Immedica Pharma AB. The same ATC class is registered in 14 of our 19 countries.

ATC S01ED01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCusimolol 0,5%ATCS01ED01REGISTER NO.PL-100189916PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about timololumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Timolol is registered in 14 of 19 countries.

Countries holding a registration under ATC S01ED01 (timolol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search timolol products by name

Timolol · ATC S01ED01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Timololum
Manufacturer
Immedica Pharma AB
Country
Poland (PL)
ATC code
S01ED01
ATC class
Timolol
Defined daily dose
0.2 g, AS
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990187713

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

144 interactions on record for timolol.

Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check timolol against other medicinesHow interaction checks work

Timolol · interactions on record

144 records

  • 28 severe
  • 114 moderate
  • 2 minor

Most severe, free to view

  • EpinephrineB02BC09severe
  • EpinephrineC01CA24severe
  • OrciprenalinC01CA29severe
  • TheophyllinC01EB28severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Timolol in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All timolol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Timoftal, Timolol Micro Labs
  • Belgium · Geltim, Timabak
  • Bulgaria · Гелтим, Кузимолол
  • Cyprus · Lithimole
  • Czechia · Oftan, Timo-Comod
  • Germany · Dispatim, Gelisia
  • Denmark · Eyopto, Optimol
  • Estonia · Timosan
  • Spain · Cusimolol, Gelisia
  • Finland · Oftan Timolol, Timosan
  • France · Geltim Lp, Genoptol
  • United Kingdom (Northern Ireland) · Eysano, Timolol Blumont Pharma
  • Greece · Geltim, Lithimole
  • Croatia · Timalen
  • Hungary · Cusimolol
  • Ireland · Timofluid, Timolol Brown & Burk Ir
  • Iceland · Timosan Depot
  • Italy · Blocadren, Cusimolol
  • Lithuania · Oftan, Timosan
  • Luxembourg · Dispatim, Geltim
  • Latvia · Oftan Timolol, Timosan
  • Malta · Lithimole
  • Netherlands · Gelisia, Timo-Comod
  • Norway · Oftan, Timosan
  • Portugal · Dibetop, Timabak
  • Romania · Gelisia, Geltim
  • Sweden · Optimol, Timosan
  • Slovenia · Timalen, Timoptic -Xe
  • Slovakia · Unitimolol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/819993f5-789d-480c-9a8e-5809adbae959
GET /v1/drugs/819993f5-789d-480c-9a8e-5809adbae959?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do oczu, roztwór",
  "source": "urpl",
  "strength": "5 mg/ml",
  "packaging": "05909990187713 ¦ Rp ¦ 2766\n1 butelka 5 ml",
  "substance": "Timololi maleas 6.83 mg",
  "common_name": "Timololum",
  "pl_product_id": "100189916",
  "pozwolenie_nr": "01877",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about timolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console